-
Product Insights
NewHemophilia A (Factor VIII Deficiency) – Drugs In Development, 2024
Empower your strategies with our Hemophilia A (Factor VIII Deficiency) – Drugs In Development, 2024 report and make more profitable business decisions. Hemophilia A is an X-linked recessive disorder caused by deficiency of functional plasma clotting factor VIII (FVIII), which may be inherited or arise from spontaneous mutation. Depending on the level of FVIII activity, patients with hemophilia may present with easy bruising, inadequate clotting of traumatic injury, or in the case of severe hemophilia, spontaneous hemorrhage. Symptoms may include bleeding...
-
Product Insights
NewHelicobacter pylori Infections – Drugs In Development, 2024
Empower your strategies with our Helicobacter pylori Infections – Drugs In Development, 2024 report and make more profitable business decisions. Helicobacter pylori (H. pylori) infection occurs when the Helicobacter pylori (H. pylori) bacteria infect the stomach, typically during childhood. A leading cause of stomach ulcers, this infection is asymptomatic for many, with over half of the global population potentially affected. Recognition often arises when peptic ulcer symptoms manifest, prompting healthcare providers to test for H. pylori. Peptic ulcers, affecting the stomach...
-
Product Insights
NewPandemic Influenza – Drugs In Development, 2024
Empower your strategies with our Pandemic Influenza – Drugs In Development, 2024 report and make more profitable business decisions. A flu pandemic is characterized by the worldwide spread of a novel flu A virus, and it occurs when this emerging virus has the capability to efficiently infect and transmit among humans, affecting a large population with limited immunity. Such pandemics are marked by the ability of the new influenza A virus to spread easily from person to person. The most recent...
-
Product Insights
NewMonkeypox – Drugs In Development, 2024
Empower your strategies with our Monkeypox – Drugs In Development, 2024 report and make more profitable business decisions. Mpox, caused by the monkeypox virus, is an infectious disease presenting with a painful rash, fever, and enlarged lymph nodes. While most individuals fully recover, some may experience severe illness. Person-to-person transmission occurs through direct contact with infectious skin or lesions, including those in the mouth or genitals. Symptoms manifest from 1-21 days after exposure, lasting 2-4 weeks or longer in individuals with...
-
Product Insights
NewInfluenza A Virus, H1N1 Subtype Infections – Drugs In Development, 2024
Empower your strategies with our Influenza A Virus, H1N1 Subtype Infections – Drugs In Development, 2024 report and make more profitable business decisions. H1N1 infection, also known as swine flu, is a new kind of flu in humans caused by a contagious influenza virus strain. H1N1 flu infects the nose, throat, and lungs. It is spread by droplets distributed by coughing or sneezing. Signs and symptoms include cough, fever, sore throat, stuffy or runny nose, body aches, headache, and fatigue. Treatment...
-
Product Insights
NewAvian Influenza – Drugs In Development, 2024
Empower your strategies with our Avian Influenza – Drugs In Development, 2024 report and make more profitable business decisions. Avian influenza, commonly referred to as bird flu, is a viral infection that primarily affects birds, especially poultry such as chickens and turkeys. Various strains of avian influenza viruses exist, some of which can cause severe illness in birds and, in certain cases, pose a risk to human health. Avian influenza viruses belong to the influenza A virus family and are classified...
-
Product Insights
NewInfluenza A Virus, H7N9 Subtype Infections – Drugs In Development, 2024
Empower your strategies with our Influenza A Virus, H7N9 Subtype Infections – Drugs In Development, 2024 report and make more profitable business decisions. Avian influenza A (H7N9) is a subtype of influenza viruses known as "bird flu". This infection is seen both in humans and birds. Infection is caused when a person is exposure to infected poultry or contaminated environments. Symptoms include fever, cough that produces sputum, headache, myalgia, and general malaise. Treatment includes antiviral drugs. The Influenza A Virus, H7N9...
-
Product Insights
NewSmallpox – Drugs In Development, 2024
Empower your strategies with our Smallpox – Drugs In Development, 2024 report and make more profitable business decisions. Smallpox was an acute contagious infection caused by the Variola virus. Symptoms include fever, malaise, headache, prostration, severe back pain, abdominal pain, and vomiting. This is followed by the development of rashes on the face, hands, forearms and the trunk. Lesions develop in the mucous membranes of the nose and mouth which ulcerate, releasing large amounts of virus into the mouth and throat....
-
Product Insights
NewDystonia – Drugs In Development, 2024
Empower your strategies with our Dystonia – Drugs In Development, 2024 report and make more profitable business decisions. Dystonia is a neurological hyperkinetic movement disorder in which sustained or repetitive muscle contractions result in twisting and repetitive movements or abnormal fixed postures. Dystonia is often intensified or exacerbated by physical activity, and symptoms may progress into adjacent muscles The Dystonia drugs in development market research report provide comprehensive information on the therapeutics under development for Dystonia, complete with analysis by stage...
-
Product Insights
NewMycobacterium tuberculosis Infections – Drugs In Development, 2024
Empower your strategies with our Mycobacterium tuberculosis Infections – Drugs In Development, 2024 report and make more profitable business decisions. The group of infections caused by Mycobacterium tuberculosis (M. tuberculosis) are referred to as Mycobacterium tuberculosis infections, which primarily affect the lungs but can also impact other parts of the body. The symptoms include persistent cough, fever, weight loss, and night sweats. Treatment typically involves a combination of antibiotics taken over several months. M. tuberculosis infections remain a significant global health...